Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FEBA SUSAN GEORGE

Allopathic & Osteopathic Physicians Hospitalist

NPI
1528452893
CMS profile
7181972
Location
PHILADELPHIA, PA

General Payments · PY2019–2024

$1,632.78

  • Reported across 53 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$387.66

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $387.66 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $131.37 5
E.R. Squibb & Sons, L.L.C. $105.54 1
PFIZER INC. $86.33 5
Boehringer Ingelheim Pharmaceuticals, Inc. $41.96 2
Amgen Inc. $22.46 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $33.83 2
PY2020 $158.31 8
PY2021 $261.99 12
PY2022 $299.54 6
PY2023 $491.45 11
PY2024 $387.66 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $22.46 10/08/2024 Food and Beverage Undisputed 01/23/2026 1111582298 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.04 02/09/2024 Food and Beverage Undisputed 01/23/2026 1118046730 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.92 06/13/2024 Food and Beverage Undisputed 01/23/2026 1118046732 CMS
E.R. Squibb & Sons, L.L.C. $105.54 05/16/2024 Food and Beverage Undisputed 01/23/2026 1101238654 CMS
Janssen Pharmaceuticals, Inc $41.32 02/08/2024 Food and Beverage Undisputed 01/23/2026 1078156925 CMS
Janssen Pharmaceuticals, Inc $25.84 04/17/2024 Food and Beverage Undisputed 01/23/2026 1078156437 CMS
Janssen Pharmaceuticals, Inc $20.67 05/16/2024 Food and Beverage Undisputed 01/23/2026 1078155603 CMS
Janssen Pharmaceuticals, Inc $20.67 06/27/2024 Food and Beverage Undisputed 01/23/2026 1078155763 CMS
Janssen Pharmaceuticals, Inc $22.87 07/25/2024 Food and Beverage Undisputed 01/23/2026 1078156631 CMS
PFIZER INC. $19.63 03/21/2024 Food and Beverage Undisputed 01/23/2026 1131085649 CMS
PFIZER INC. $14.89 05/03/2024 Food and Beverage Undisputed 01/23/2026 1131544129 CMS
PFIZER INC. $16.07 08/28/2024 Food and Beverage Undisputed 01/23/2026 1131860475 CMS
PFIZER INC. $19.57 11/13/2024 Food and Beverage Undisputed 01/23/2026 1131169124 CMS
PFIZER INC. $16.17 12/13/2024 Food and Beverage Undisputed 01/23/2026 1131047266 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.